← Back to Clinical Trials
Recruiting NCT06065514

The Role of Inflammation in Myocardial Infarction

Trial Parameters

Condition Myocardial Infarction
Sponsor Nicosia General Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-08-24
Completion 2025-03-30

Brief Summary

The aim of this research is to study the prognostic role of a selected combination of cytokines and adipokines in patients with myocardial infarction, as well as to determine their role in the development of adverse cardiac remodeling.

Eligibility Criteria

Inclusion Criteria: 1. ACS (ST-ACS, NSTE-ACS, UA) referred for coronary angiography 2. Above 18 years old 3. Consent form obtained Exclusion Criteria: 1. Chronic Renal Failure (CRF) stage IV (e GFR \< 29 ml/min or creatinine \> 2 mg/dl) 2. Chronic Liver Disease (CLD) (ALT \> 2 times upper normal limit) 3. Chronic Inflammation and/or autoimmune diseases 4. Active Ca 5. Recent CVA (less than 1 month) 6. Recent (within 2 weeks) use of glucocorticoid drugs or immunosuppressive agents 7. Acute or chronic infection, major surgery, or trauma in the last month 8. Previous heart transplantation 9. Poor life expectancy 10. Cardiogenic shock 11. Cardiac arrest

Related Trials